Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conivaptan dosing regimens in hyponatremia
NCT00435591Phase 4Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Jan 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of conivaptan in hyponatremia, sponsored by Cumberland Pharmaceuticals. Started Jan 2007; status: completed.
02
Drugs
conivaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT00435591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435591.